Abstract:Plasmodium falciparum (Pf), the causative agent of malaria, has an iron-sulfur cluster-containing class I fumarate hydratase (FH) that catalyzes the interconversion of fumarate to malate, a wellknown reaction in the tricarboxylic acid cycle. In humans, the same reaction is catalyzed by class II FH that has no sequence or structural homology with the class I enzyme from Plasmodium. Fumarate is generated in large quantities in the parasite as a byproduct of AMP synthesis and is converted to malate by FH and then… Show more
“…Ferredoxin (PF3D7_1214600) is expected to be essential (18), but its main role is to provide electrons for the ISC pathway (39). Class I fumarate hydratase (PF3D7_0927300), which functions in the TCA cycle but may also contribute to purine scavenging, was refractory to disruption in P. falciparum (7) but successfully deleted in P. berghei in a mouse strain-dependent manner (40).…”
Section: Resultsmentioning
confidence: 99%
“…Ferredoxin (PF3D7_1214600) is expected to be essential (19), but its main role is to provide electrons for the ISC pathway (43). Class I fumarate hydratase (PF3D7_0927300), which functions in the TCA cycle but may also contribute to purine scavenging, was refractory to disruption in P. falciparum (8) but successfully deleted in P. berghei in a mouse strain-dependent manner (44). The Rieske protein (PF3D7_1439400), which is an essential component of ETC complex III (45), is the only known mitochondrial Fe-S cluster protein that has an unequivocally essential function apart from the ISC pathway.…”
Plasmodium falciparum malaria parasites are early-diverging eukaryotes with many unusual metabolic adaptations. Understanding these adaptations will give insight into parasite evolution and unveil new parasite-specific drug targets. In contrast to human cells, the Plasmodium mitochondrion lacks type II fatty acid biosynthesis (FASII) enzymes yet curiously retains a divergent acyl carrier protein (mACP) incapable of modification by a 4-phosphopantetheine (Ppant) group required for canonical ACP function as the scaffold for fatty acid synthesis. We report that ligand-dependent knockdown of mACP expression is lethal to parasites, indicating an essential FASII-independent function. Decyl-ubiquinone rescues parasites temporarily from this lethal phenotype, suggesting a dominant dysfunction of the mitochondrial electron transport chain (ETC) followed by broader defects beyond the ETC. Biochemical studies reveal that Plasmodium mACP binds and stabilizes the Isd11-Nfs1 cysteine desulfurase complex required for Fe-S cluster biosynthesis, and mACP knockdown causes loss of both Nfs1 and the Rieske Fe-S cluster protein in ETC Complex III. This work identifies Ppant-independent mACP as an essential mitochondrial adaptation in Plasmodium malaria parasites that appears to be a shared metabolic feature of Apicomplexan pathogens, including Toxoplasma and Babesia. This parasite-specific adaptation highlights the ancient, fundamental role of ACP in mitochondrial Fe-S cluster biogenesis and reveals an evolutionary driving force to retain this interaction with ACP independent of its eponymous function in fatty acid synthesis.
“…Ferredoxin (PF3D7_1214600) is expected to be essential (18), but its main role is to provide electrons for the ISC pathway (39). Class I fumarate hydratase (PF3D7_0927300), which functions in the TCA cycle but may also contribute to purine scavenging, was refractory to disruption in P. falciparum (7) but successfully deleted in P. berghei in a mouse strain-dependent manner (40).…”
Section: Resultsmentioning
confidence: 99%
“…Ferredoxin (PF3D7_1214600) is expected to be essential (19), but its main role is to provide electrons for the ISC pathway (43). Class I fumarate hydratase (PF3D7_0927300), which functions in the TCA cycle but may also contribute to purine scavenging, was refractory to disruption in P. falciparum (8) but successfully deleted in P. berghei in a mouse strain-dependent manner (44). The Rieske protein (PF3D7_1439400), which is an essential component of ETC complex III (45), is the only known mitochondrial Fe-S cluster protein that has an unequivocally essential function apart from the ISC pathway.…”
Plasmodium falciparum malaria parasites are early-diverging eukaryotes with many unusual metabolic adaptations. Understanding these adaptations will give insight into parasite evolution and unveil new parasite-specific drug targets. In contrast to human cells, the Plasmodium mitochondrion lacks type II fatty acid biosynthesis (FASII) enzymes yet curiously retains a divergent acyl carrier protein (mACP) incapable of modification by a 4-phosphopantetheine (Ppant) group required for canonical ACP function as the scaffold for fatty acid synthesis. We report that ligand-dependent knockdown of mACP expression is lethal to parasites, indicating an essential FASII-independent function. Decyl-ubiquinone rescues parasites temporarily from this lethal phenotype, suggesting a dominant dysfunction of the mitochondrial electron transport chain (ETC) followed by broader defects beyond the ETC. Biochemical studies reveal that Plasmodium mACP binds and stabilizes the Isd11-Nfs1 cysteine desulfurase complex required for Fe-S cluster biosynthesis, and mACP knockdown causes loss of both Nfs1 and the Rieske Fe-S cluster protein in ETC Complex III. This work identifies Ppant-independent mACP as an essential mitochondrial adaptation in Plasmodium malaria parasites that appears to be a shared metabolic feature of Apicomplexan pathogens, including Toxoplasma and Babesia. This parasite-specific adaptation highlights the ancient, fundamental role of ACP in mitochondrial Fe-S cluster biogenesis and reveals an evolutionary driving force to retain this interaction with ACP independent of its eponymous function in fatty acid synthesis.
“…Recently it was shown that 2-thiomalate is also a micromolar inhibitor of class I FHs from parasites Trypanosoma cruzi and Plasmodium falciparum but does not inhibit human FH. 10 , 11 To our knowledge, 2-thiomalate is the first selective small molecule inhibitor of class I FHs, and here we show that this selectivity arises from the binding of the inhibitor to the class I FH catalytic [4Fe-4S] cluster; the human class II FH does not utilize a [4Fe-4S] cluster. In addition, LmFH-1 and LmFH-2 structures show high structural similarity, indicating that inhibitors of one isoform are likely to inhibit the other isoform.…”
mentioning
confidence: 58%
“…2-Thiomalate has also been identified as a micromolar competitive inhibitor of class I FHs from Trypanosoma cruzi ( K i, malate = 4.2 ± 0.5 μM for cytosolic isoform; K i, malate = 1.3 ± 0.1 μM for mitochondrial isoform) and Plasmodium falciparum ( K i = 0.32 ± 0.03 μM for S -malate; K i = 0.55 ± 0.05 μM for fumarate) but does not inhibit class II human FH. 10 , 11 To our knowledge, 2-thiomalate is the first selective inhibitor of class I FHs.…”
Section: Discussionmentioning
confidence: 98%
“… 7 , 8 Class I FHs are [4Fe-4S] cluster-containing dimeric enzymes found in archaea, prokaryotes, and unicellular eukaryotes, including protozoan parasites. 9 − 11 Class II FHs are iron-independent tetrameric enzymes found in prokaryotes and eukaryotes, including humans. 12 Thus, class I FHs are considered attractive drug targets because they are structurally distinct from class II human FH and play vital roles in multiple metabolic pathways.…”
Leishmaniases
affect the poorest people on earth and have no effective
drug therapy. Here, we present the crystal structure of the mitochondrial
isoform of class I fumarate hydratase (FH) from
Leishmania
major
and compare it to the previously determined cytosolic
Leishmania major
isoform. We further describe the mechanism
of action of the first class-specific FH inhibitor, 2-thiomalate,
through X-ray crystallography and inhibition assays. Our crystal structures
of both FH isoforms with inhibitor bound at 2.05 Å resolution
and 1.60 Å resolution show high structural similarity. These
structures further reveal that the selectivity of 2-thiomalate for
class I FHs is due to direct coordination of the inhibitor to the
unique Fe of the catalytic [4Fe-4S] cluster that is found in class
I parasitic FHs but is absent from class II human FH. These studies
provide the structural scaffold in order to exploit class I FHs as
potential drug targets against leishmaniases as well as Chagas diseases,
sleeping sickness, and malaria.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.